Substantial Changes To CAS Administration Regulations
Client Alert | 1 min read | 03.16.05
Final rules, effective April 8, 2005, concerning proposed changes to CAS administration requirements that have been pending since April 2000 were promulgated on March 9, 2005 (70 Fed. Reg. 11743-61). The new regulations will be discussed in detail at the upcoming OOPS/WOOPS programs on March 31-April 1/April 14-15, but some of the highlights include:
- When there is a CAS noncompliance, contract price adjustments may be required for closed contracts and closed years,
- Improvement in the definition of "desirable" and "required" changes may permit contractors to avoid price adjustments,
- Retroactive accounting changes are permitted in limited circumstances,
- Widely criticized proposals to prohibit offsets between FFP and flexibly-priced contracts were abandoned, and
- Estimates to complete rather than original cost estimates must be used to determine cost impact on FFP contracts.
Insights
Client Alert | 2 min read | 09.18.25
On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”
Client Alert | 3 min read | 09.17.25
Client Alert | 4 min read | 09.17.25
Client Alert | 5 min read | 09.16.25
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today
